Journals of Gerontology Series A: Biological Sciences and Medical Sciences Large Type Edition
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]
Author:
Keyword(s):
Year:  Vol:  Page: 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Cited by other online articles
Google Scholar
Right arrow Articles by Davis, T.
Right arrow Articles by Kipling, D.
Right arrow Articles citing this Article
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davis, T.
Right arrow Articles by Kipling, D.
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 60:1386-1393 (2005)
© 2005 The Gerontological Society of America

Prevention of Accelerated Cell Aging in Werner Syndrome Using a p38 Mitogen-Activated Protein Kinase Inhibitor

Terence Davis, Duncan M. Baird, Michèle F. Haughton, Christopher J. Jones and David Kipling

Department of Pathology, School of Medicine, Cardiff University, Wales, United Kingdom.

Address correspondence to David Kipling, D.Phil, Department of Pathology, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, United Kingdom. E-mail: kiplingd{at}cardiff.ac.uk

We investigated the role of p38 mitogen-activated protein kinase (MAPK) signalling in the accelerated aging of Werner Syndrome (WS) fibroblasts by use of SB203580, a cytokine-suppressive anti-inflammatory drug that targets p38 activity. SB203580 treatment reverts the aged morphology of young WS fibroblasts to that seen in young normal fibroblasts. In addition, SB203580 increases the life span and growth rate of WS fibroblasts to within the normal range. In young WS cells, p38 is activated coincident with an up-regulation of p21WAF1, and a reduction in the levels of both activated p38 and p21WAF1 are seen following treatment with SB203580. As these effects are not seen in young normal cells, our data suggest that the abbreviated replicative life span of WS cells is due to a stress-induced, p38-mediated growth arrest that is independent of telomere erosion. With some p38 inhibitors already in clinical trials, our data suggest a potential route to drug intervention in a premature aging syndrome.




This article has been cited by other articles: (Search Google Scholar for Other Citing Articles)


Home page
SCI AGING KNOWL ENVIRONHome page
F. M. Hisama, V. A. Bohr, and J. Oshima
WRN's Tenth Anniversary
Sci. Aging Knowl. Environ., June 28, 2006; 2006(10): pe18 - pe18.
[Abstract] [Full Text]


Home page
Annals NYAS OnlineHome page
T. DAVIS, M. F. HAUGHTON, C. J. JONES, and D. KIPLING
Prevention of Accelerated Cell Aging in the Werner Syndrome
Ann. N.Y. Acad. Sci., May 1, 2006; 1067(1): 243 - 247.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
All GSA journals The Gerontologist
Journals of Gerontology Series B: Psychological Sciences and Social Sciences
Copyright © 2005 by The Gerontological Society of America.